Table 2.
Variables | Levels | CAM (n = 106; 46%) | No CAM (n = 127; 54%) | Bivariate analysis |
Multivariate analysis |
||||
---|---|---|---|---|---|---|---|---|---|
p-value | ORb | 95% CIc | p-value | OR | 95% CI | ||||
Age in years, mean ± SDa (range) | 56 ± 11.2 (24–78) | 58 ± 12 (33–85) | 0.276 | ||||||
Gender Males, n (%) | 76 (72) | 95 (75) | 0.285 | 0.853 | 0.48–1.53 | ||||
Age onset PD in years, mean ± SD (range) | 49 ± 11.16 (17–76) | 52 ± 11.34 (29–76) | 0.042 | 0.976 | 0.95–0.99 | 0.048 | 0.968 | 0.94–1.00 | |
Duration PD, months; n (%) | <36 | 19 (18) | 38 (30) | 0.001 | 1 | 0.003 | 1 | ||
36–72 | 16 (15) | 44 (35) | 0.727 | 0.33–1.61 | 0.913 | 0.37–2.24 | |||
>72 | 71 (58) | 45 (35) | 3.156 | 1.62–6.14 | 3.081 | 1.48–6.43 | |||
PD type | Tremor | 56 (53) | 73 (58) | 0.477 | 0.828 | 0.49–1.39 | |||
Akinetic-rigid | 50 (48) | 54 (43) | 1.00 | ||||||
dH & Y Stage, mean ± SD (range) | 2.35 ± 0.79 (1–4) | 2.18 ± 0.68 (1–4) | 0.156 | 0.120 | −0.65–0.40 | ||||
eUPDRS-III mean ± SD (range) | 28 ± 11.73 (11–60) | 22 ± 11.0 (4–59) | 0.008 | 1.044 | 1.01–1.08 | ||||
gLD/CD prescribed | Yes | 77 (73) | 70 (55) | 0.006 | 2.162 | 1.25–3.75 | |||
No | 29 (27) | 57 (45) | |||||||
LD Dose; mg/day in-group, n (%) | <250 | 14 (20) | 18 (23) | 0.801 | |||||
250–400 | 30 (43) | 27 (35) | |||||||
400–600 | 13 (19) | 15 (20) | |||||||
>600 | 13 (19) | 17 (22) | |||||||
fLEDD; mean ± SD (range) | 787.7 ± 431 (100–2500) | 724.5 ± 435 (30–2149) | 0.174 | ||||||
Initial LD response | >70% | 63 (59) | 63 (50) | 0.532 | |||||
25-69% | 22 (21) | 37 (29) | |||||||
<25% | 8 (8) | 7 (6) | |||||||
No response | 5 (5) | 5 (3) | |||||||
Cannot qualify | 8 (8) | 15 (12) | |||||||
Current LD response | >70% | 45 (43) | 51 (40) | 0.736 | |||||
25–69% | 34 (32) | 44 (35) | |||||||
<25% | 12 (11) | 11 (9) | |||||||
No response | 7 (7) | 6 (5) | |||||||
Cannot qualify | 8 (8) | 15 (12) | |||||||
Perceived health, n (%) | Quite bad | 7 (7) | 1 (1) | 0.001 | <0.001 | 1 | |||
Bad | 19 (14) | 16 (13) | 0.424 | 0.390 | 0.04–3.91 | ||||
Fairly good | 62 (59) | 59 (47) | 0.199 | 0.234 | 0.03–2.15 | ||||
Good | 18 (17) | 51 (41) | 0.017 | 0.004 | 0.01–0.61 | ||||
Education | Illiterate | 4 (3.8) | 11 (8.7) | 0.002 | 1 | 0.006 | 1 | ||
<X std. | 13 (12) | 36 (28) | 0.992 | 0.993 | 0.27–3.67 | 0.985 | 1.014 | 0.24–4.25 | |
X/XII std. | 31 (29) | 38 (30) | 0.201 | 2.243 | 0.65–7.74 | 0.315 | 0.205 | 0.52–7.76 | |
>Graduate | 58 (55) | 44 (33) | 0.031 | 3.798 | 1.13–12.75 | 0.040 | 0.049 | 1.07–15.35 | |
Distance from hospital, hKm; n (%) | <100 | 62 (58) | 83 (65) | 0.254 | |||||
100–200 | 15 (14) | 9 (7) | |||||||
200–500 | 10 (9) | 16 (13) | |||||||
>500 | 19 (18) | 19 (15) | |||||||
Location, n(%) | Rural | 5 (4.7) | 24 (19) | 0.001 | 1.00 | 0.011 | 1.00 | ||
Urban | 101 (95) | 103 (81) | 0.002 | 4.707 | 1.73–12.82 | 4.119 | 1.38–12.29 |
Bold values are the values which are statistically significant.
Standard deviation.
Odds ratio.
confidence interval.
modified Hoehn & Yahr stage.
Unified Parkinson's disease rating scale.
Levodopa equivalent daily dose.
Levodopa/Carbidopa.
Kilometer.